[at Seeking Alpha] – In January, Bristol-Myers Squibb ( BMY ) , will start a Phase 2 study in patients with glioblastoma. The trial is part of a series in which Bristol combines its experimental drug, nivolumab, with the approved …
Read … [visit site to read more]
- Company Update: Bristol-Myers Squibb Company (NYSE:BMY) – ModernGraham Valuation Of Bristol-Myers Squibb Co.
- Bristol-Myers Squibb Company (NYSE:BMY) | Bristol-Myers Squibb Announces Changes in Senior Management Team
- Company Update – Bristol-Myers Squibb Company (NYSE:BMY) – Bristol-Myers Vs. Abbvie In Potential Humira Rivalry